{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:37:16Z","timestamp":1790743036478,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T00:00:00Z","timestamp":1426204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11010-015-2383-5","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T08:57:43Z","timestamp":1426150663000},"page":"241-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes"],"prefix":"10.1007","volume":"404","author":[{"given":"Varun","family":"Kesherwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Sundar","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surender K.","family":"Sharawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid R.","family":"Shahshahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,13]]},"reference":[{"key":"2383_CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly P, Alam SF (2015) Role of homocysteine in the development of cardiovascular disease. Nutr J 14:6","journal-title":"Nutr J"},{"key":"2383_CR2","first-page":"1","volume":"5","author":"KS McCully","year":"2015","unstructured":"McCully KS (2015) Homocysteine and the pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol 5:1\u20139","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2383_CR3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nygard","year":"1997","unstructured":"Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230\u2013236","journal-title":"N Engl J Med"},{"key":"2383_CR4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0496-386","volume":"2","author":"KS McCully","year":"1996","unstructured":"McCully KS (1996) Homocysteine and vascular disease. Nat Med 2:386\u2013389","journal-title":"Nat Med"},{"key":"2383_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12013-009-9063-6","volume":"55","author":"PK Mishra","year":"2009","unstructured":"Mishra PK, Tyagi N, Kundu S, Tyagi SC (2009) MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell Biochem Biophys 55:153\u2013162","journal-title":"Cell Biochem Biophys"},{"key":"2383_CR6","first-page":"79","volume":"5","author":"TP Vacek","year":"2009","unstructured":"Vacek TP, Sen U, Tyagi N, Vacek JC, Kumar M, Hughes WM et al (2009) Differential expression of Gs in a murine model of homocysteinemic heart failure. Vasc Health Risk Manag 5:79\u201384","journal-title":"Vasc Health Risk Manag"},{"key":"2383_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12013-010-9079-y","volume":"57","author":"U Sen","year":"2010","unstructured":"Sen U, Mishra PK, Tyagi N, Tyagi SC (2010) Homocysteine to hydrogen sulfide or hypertension. Cell Biochem Biophys 57:49\u201358","journal-title":"Cell Biochem Biophys"},{"key":"2383_CR8","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1253\/circj.CJ-14-0728","volume":"78","author":"LA Barr","year":"2014","unstructured":"Barr LA, Calvert JW (2014) Discoveries of hydrogen sulfide as a novel cardiovascular therapeutic. Circ J 78:2111\u20132118","journal-title":"Circ J"},{"key":"2383_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCULATIONAHA.109.920991","volume":"122","author":"JW Calvert","year":"2010","unstructured":"Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW et al (2010) Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 122:11\u201319","journal-title":"Circulation"},{"key":"2383_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20100462","volume":"120","author":"M Lavu","year":"2011","unstructured":"Lavu M, Bhushan S, Lefer DJ (2011) Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential. Clin Sci (Lond) 120:219\u2013229","journal-title":"Clin Sci (Lond)"},{"key":"2383_CR11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/CS20140668","volume":"128","author":"VB Patel","year":"2015","unstructured":"Patel VB, McLean BA, Chen X, Oudit GY (2015) Hydrogen sulfide: an old gas with new cardioprotective effects. Clin Sci (Lond) 128:321\u2013323","journal-title":"Clin Sci (Lond)"},{"key":"2383_CR12","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1073\/pnas.0705891104","volume":"104","author":"JW Elrod","year":"2007","unstructured":"Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L et al (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104:15560\u201315565","journal-title":"Proc Natl Acad Sci USA"},{"key":"2383_CR13","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/mmr.2014.2901","volume":"11","author":"Z Wu","year":"2015","unstructured":"Wu Z, Peng H, Du Q, Lin W, Liu Y (2015) GYY4137, a hydrogen sulfide-releasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factor kappa B and mitogen-activated protein kinases in Coxsackie virus B3-infected rat cardiomyocytes. Mol Med Rep 11:1837\u20131844","journal-title":"Mol Med Rep"},{"key":"2383_CR14","author":"LA Barr","year":"2015","unstructured":"Barr LA, Shimizu Y, Lambert JP, Nicholson CK, Calvert JW (2015) Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress. Nitric Oxide. doi: 10.1016\/j.niox.2014.12.013","journal-title":"Nitric Oxide"},{"key":"2383_CR15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","volume":"105","author":"JW Calvert","year":"2009","unstructured":"Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB et al (2009) Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105:365\u2013374","journal-title":"Circ Res"},{"key":"2383_CR16","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1073\/pnas.1321871111","volume":"111","author":"AL King","year":"2014","unstructured":"King AL, Polhemus DJ, Bhushan S, Otsuka H, Kondo K, Nicholson CK et al (2014) Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proc Natl Acad Sci USA 111:3182\u20133187","journal-title":"Proc Natl Acad Sci USA"},{"key":"2383_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215\u2013233","journal-title":"Cell"},{"key":"2383_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2010.09.006","volume":"401","author":"PK Mishra","year":"2010","unstructured":"Mishra PK, Givvimani S, Metreveli N, Tyagi SC (2010) Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy. Biochem Biophys Res Commun 401:175\u2013181","journal-title":"Biochem Biophys Res Commun"},{"key":"2383_CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/157339911797579179","volume":"7","author":"AC Tyagi","year":"2011","unstructured":"Tyagi AC, Sen U, Mishra PK (2011) Synergy of microRNA and stem cell: a novel therapeutic approach for diabetes mellitus and cardiovascular diseases. Curr Diabetes Rev 7:367\u2013376","journal-title":"Curr Diabetes Rev"},{"key":"2383_CR20","doi-asserted-by":"crossref","first-page":"e57800","DOI":"10.1371\/journal.pone.0057800","volume":"8","author":"S Leptidis","year":"2013","unstructured":"Leptidis S, El Azzouzi H, Lok SI, de Weger R, Olieslagers S, Kisters N et al (2013) A deep sequencing approach to uncover the miRNOME in the human heart. PLoS ONE 8:e57800","journal-title":"PLoS ONE"},{"key":"2383_CR21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/00365513.2014.905696","volume":"74","author":"PL Hedley","year":"2014","unstructured":"Hedley PL, Carlsen AL, Christiansen KM, Kanters JK, Behr ER, Corfield VA et al (2014) MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome. Scand J Clin Lab Invest 74:485\u2013491","journal-title":"Scand J Clin Lab Invest"},{"key":"2383_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jcmm.12218","volume":"18","author":"S Chen","year":"2014","unstructured":"Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW, Chakrabarti S (2014) Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med 18:415\u2013421","journal-title":"J Cell Mol Med"},{"key":"2383_CR23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","volume":"106","author":"SJ Matkovich","year":"2010","unstructured":"Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, LE Dorn, Condorelli G et al (2010) MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 106:166\u2013175","journal-title":"Circ Res"},{"key":"2383_CR24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613\u2013618","journal-title":"Nat Med"},{"key":"2383_CR25","doi-asserted-by":"crossref","first-page":"20844","DOI":"10.1073\/pnas.0710558105","volume":"104","author":"N Liu","year":"2007","unstructured":"Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB et al (2007) An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci USA 104:20844\u201320849","journal-title":"Proc Natl Acad Sci USA"},{"key":"2383_CR26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/embor.2009.88","volume":"10","author":"A Nebbioso","year":"2009","unstructured":"Nebbioso A, Manzo F, Miceli M, Conte M, Manente L, Baldi A et al (2009) Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC\u2013MEF2 complexes. EMBO Rep 10:776\u2013782","journal-title":"EMBO Rep"},{"key":"2383_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","volume":"72","author":"L Brattstrom","year":"2000","unstructured":"Brattstrom L, Wilcken DE (2000) Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72:315\u2013323","journal-title":"Am J Clin Nutr"},{"key":"2383_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12013-013-9679-4","volume":"68","author":"V Chavali","year":"2014","unstructured":"Chavali V, Tyagi SC, Mishra PK (2014) Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+\/\u2212 Akita hearts. Cell Biochem Biophys 68:25\u201335","journal-title":"Cell Biochem Biophys"},{"key":"2383_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.med.60.041807.123308","volume":"60","author":"BA Maron","year":"2009","unstructured":"Maron BA, Loscalzo J (2009) The treatment of hyperhomocysteinemia. Annu Rev Med 60:39\u201354","journal-title":"Annu Rev Med"},{"key":"2383_CR30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbrc.2011.08.101","volume":"413","author":"J Liu","year":"2011","unstructured":"Liu J, Hao DD, Zhang JS, Zhu YC (2011) Hydrogen sulphide inhibits cardiomyocyte hypertrophy by up-regulating miR-133a. Biochem Biophys Res Commun 413:342\u2013347","journal-title":"Biochem Biophys Res Commun"},{"key":"2383_CR31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2012.07.105","volume":"425","author":"V Chavali","year":"2012","unstructured":"Chavali V, Tyagi SC, Mishra PK (2012) MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes. Biochem Biophys Res Commun 425:668\u2013672","journal-title":"Biochem Biophys Res Commun"},{"key":"2383_CR32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1614438","volume":"81","author":"M Cattaneo","year":"1999","unstructured":"Cattaneo M (1999) Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 81:165\u2013176","journal-title":"Thromb Haemost"},{"key":"2383_CR33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.ATV.21.1.74","volume":"21","author":"A Jager","year":"2001","unstructured":"Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM et al (2001) Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol 21:74\u201381","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2383_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1475-2840-9-49","volume":"9","author":"PK Mishra","year":"2010","unstructured":"Mishra PK, Tyagi N, Sen U, Joshua IG, Tyagi SC (2010) Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol. Cardiovasc Diabetol 9:49","journal-title":"Cardiovasc Diabetol"},{"key":"2383_CR35","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","volume":"354","author":"KH Bonaa","year":"2006","unstructured":"Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T et al (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578\u20131588","journal-title":"N Engl J Med"},{"key":"2383_CR36","first-page":"CD006612","volume":"1","author":"AJ Marti-Carvajal","year":"2009","unstructured":"Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 1:CD006612","journal-title":"Cochrane Database Syst Rev"},{"key":"2383_CR37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E Lonn","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M et al (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567\u20131577","journal-title":"N Engl J Med"},{"key":"2383_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/157489009787259991","volume":"4","author":"E Vizzardi","year":"2009","unstructured":"Vizzardi E, Bonadei I, Zanini G, Frattini S, Fiorina C, Raddino R et al (2009) Homocysteine and heart failure: an overview. Recent Pat Cardiovasc Drug Discov 4:15\u201321","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"2383_CR39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.1054","volume":"26","author":"B Feng","year":"2010","unstructured":"Feng B, Chen S, George B, Feng Q, Chakrabarti S (2010) miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 26:40\u201349","journal-title":"Diabetes Metab Res Rev"},{"key":"2383_CR40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/med.20234","volume":"32","author":"A Martelli","year":"2012","unstructured":"Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S et al (2012) Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 32:1093\u20131130","journal-title":"Med Res Rev"},{"key":"2383_CR41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1162667","volume":"322","author":"G Yang","year":"2008","unstructured":"Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K et al (2008) H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322:587\u2013590","journal-title":"Science"},{"key":"2383_CR42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2007.05.026","volume":"76","author":"WJ Cai","year":"2007","unstructured":"Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC (2007) The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 76:29\u201340","journal-title":"Cardiovasc Res"},{"key":"2383_CR43","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1124\/jpet.109.150532","volume":"329","author":"R Tamizhselvi","year":"2009","unstructured":"Tamizhselvi R, Sun J, Koh YH, Bhatia M (2009) Effect of hydrogen sulfide on the phosphatidylinositol 3-kinase-protein kinase B pathway and on caerulein-induced cytokine production in isolated mouse pancreatic acinar cells. J Pharmacol Exp Ther 329:1166\u20131177","journal-title":"J Pharmacol Exp Ther"},{"key":"2383_CR44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3892\/mmr.2012.748","volume":"5","author":"J Huang","year":"2012","unstructured":"Huang J, Wang D, Zheng J, Huang X, Jin H (2012) Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats. Mol Med Rep 5:923\u2013928","journal-title":"Mol Med Rep"},{"key":"2383_CR45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00726-007-0011-8","volume":"34","author":"L Chang","year":"2008","unstructured":"Chang L, Geng B, Yu F, Zhao J, Jiang H, Du J et al (2008) Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 34:573\u2013585","journal-title":"Amino Acids"},{"key":"2383_CR46","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.RES.82.7.773","volume":"82","author":"KL Vikstrom","year":"1998","unstructured":"Vikstrom KL, Bohlmeyer T, Factor SM, Leinwand LA (1998) Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res 82:773\u2013778","journal-title":"Circ Res"},{"key":"2383_CR47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1157\/13087900","volume":"59","author":"JE Carreno","year":"2006","unstructured":"Carreno JE, Apablaza F, Ocaranza MP, Jalil JE (2006) Cardiac hypertrophy: molecular and cellular events. Rev Esp Cardiol 59:473\u2013486","journal-title":"Rev Esp Cardiol"},{"key":"2383_CR48","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1074\/jbc.M707886200","volume":"283","author":"CW Woo","year":"2008","unstructured":"Woo CW, Siow YL, Karmin O (2008) Homocysteine induces monocyte chemoattractant protein-1 expression in hepatocytes mediated via activator protein-1 activation. J Biol Chem 283:1282\u20131292","journal-title":"J Biol Chem"},{"key":"2383_CR49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/FJC.0b013e3181de308b","volume":"56","author":"SA Pal","year":"2010","unstructured":"Pal SA, Kaur T, SinghDahiya R, Singh N, Singh Bedi PM (2010) Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy. J Cardiovasc Pharmacol 56:53\u201359","journal-title":"J Cardiovasc Pharmacol"},{"key":"2383_CR50","doi-asserted-by":"crossref","first-page":"e63291","DOI":"10.1371\/journal.pone.0063291","volume":"8","author":"PM Snijder","year":"2013","unstructured":"Snijder PM, de Boer RA, Bos EM, van den Born JC, Ruifrok WP, Vreeswijk-Baudoin I et al (2013) Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism. PLoS ONE 8:e63291","journal-title":"PLoS ONE"},{"key":"2383_CR51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","volume":"104","author":"RF Duisters","year":"2009","unstructured":"Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I et al (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104:170\u2013178","journal-title":"Circ Res"},{"key":"2383_CR52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/CIRCGENETICS.113.000381","volume":"7","author":"S Toldo","year":"2014","unstructured":"Toldo S, Das A, Mezzaroma E, Chau VQ, Marchetti C, Durrant D et al (2014) Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice. Circ Cardiovasc Genet 7:311\u2013320","journal-title":"Circ Cardiovasc Genet"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-015-2383-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-015-2383-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-015-2383-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T22:22:41Z","timestamp":1566426161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-015-2383-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,13]]},"references-count":52,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2383"],"URL":"https:\/\/doi.org\/10.1007\/s11010-015-2383-5","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,13]]}}}